rs145620748

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 2P and 14B. PM1BP4_StrongBP6_ModerateBS1BS2

The NM_000397.4(CYBB):​c.1159G>A​(p.Val387Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000752 in 1,210,124 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., 11 hem., cov: 24)
Exomes 𝑓: 0.000038 ( 0 hom. 13 hem. )

Consequence

CYBB
NM_000397.4 missense

Scores

1
6
10

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 4.41

Publications

0 publications found
Variant links:
Genes affected
CYBB (HGNC:2578): (cytochrome b-245 beta chain) Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole. [provided by RefSeq, Jul 2008]
CYBB Gene-Disease associations (from GenCC):
  • granulomatous disease, chronic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic granulomatous disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency
    Inheritance: XL, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000397.4
BP4
Computational evidence support a benign effect (MetaRNN=0.04415235).
BP6
Variant X-37805013-G-A is Benign according to our data. Variant chrX-37805013-G-A is described in ClinVar as Benign. ClinVar VariationId is 533559.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000435 (49/112688) while in subpopulation AFR AF = 0.00151 (47/31054). AF 95% confidence interval is 0.00117. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 11 XL,AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYBBNM_000397.4 linkc.1159G>A p.Val387Ile missense_variant Exon 10 of 13 ENST00000378588.5 NP_000388.2
CYBBXM_047441855.1 linkc.853G>A p.Val285Ile missense_variant Exon 9 of 12 XP_047297811.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYBBENST00000378588.5 linkc.1159G>A p.Val387Ile missense_variant Exon 10 of 13 1 NM_000397.4 ENSP00000367851.4
ENSG00000250349ENST00000465127.1 linkc.171+379013G>A intron_variant Intron 3 of 8 5 ENSP00000417050.1

Frequencies

GnomAD3 genomes
AF:
0.000435
AC:
49
AN:
112637
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000187
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000142
AC:
26
AN:
182708
AF XY:
0.000148
show subpopulations
Gnomad AFR exome
AF:
0.00152
Gnomad AMR exome
AF:
0.000220
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000383
AC:
42
AN:
1097436
Hom.:
0
Cov.:
30
AF XY:
0.0000358
AC XY:
13
AN XY:
363038
show subpopulations
African (AFR)
AF:
0.00129
AC:
34
AN:
26361
American (AMR)
AF:
0.000171
AC:
6
AN:
35129
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19367
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30195
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54137
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40499
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4112
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841584
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000435
AC:
49
AN:
112688
Hom.:
0
Cov.:
24
AF XY:
0.000316
AC XY:
11
AN XY:
34862
show subpopulations
African (AFR)
AF:
0.00151
AC:
47
AN:
31054
American (AMR)
AF:
0.000187
AC:
2
AN:
10685
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3575
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6199
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53316
Other (OTH)
AF:
0.00
AC:
0
AN:
1531
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.533
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0261
Hom.:
2358
Bravo
AF:
0.000548
ESP6500AA
AF:
0.00130
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000239
AC:
29

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Granulomatous disease, chronic, X-linked Benign:1
Oct 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CYBB-related disorder Benign:1
Oct 16, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.38
T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.69
D
MetaRNN
Benign
0.044
T
MetaSVM
Uncertain
0.099
D
MutationAssessor
Benign
0.34
N
PhyloP100
4.4
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.47
N
REVEL
Uncertain
0.42
Sift
Benign
0.49
T
Sift4G
Benign
0.48
T
Polyphen
0.47
P
Vest4
0.30
MVP
0.81
MPC
0.69
ClinPred
0.043
T
GERP RS
5.9
Varity_R
0.40
gMVP
0.31
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145620748; hg19: chrX-37664266; API